Floatz logo

Orca-Q

Chronic Myeloid Leukemia in Myeloid Blast Crisis

University of FloridaCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

42 Active assets in the Chronic Myeloid Leukemia in Myeloid Blast Crisis cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 2BBB
Cyclophosphamide
Ohio State University Comprehensive Cancer Center
Phase 2BBB
TACROLIMUS
University of Michigan Rogel Cancer Center
Phase 2BB
Imatinib
The University of Hong Kong
Phase 2BB
METHOTREXATE
University of Michigan Rogel Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Orca-Q is also rated in:

acute lymphoblastic leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
mixed phenotype acute leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
Chronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis)Dormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →